Uterine myomas (fibroids) are benign tumors of the uterus. Myomectomy, the surgical removal of the myomas, is an important treatment option, especially for women who desire to preserve their uteri. The major problem with myomectomy is excessive bleeding from the increased uterine blood supply, which can be lifethreatening and prolong post-operative stay. Knowledge of the effectiveness of the interventions used to reduce blood loss during myomectomy is essential to enable evidence-based clinical decisions.